This document summarizes the clinical development solutions offered by Covance for cell and gene therapies. Covance has expertise in oncology, rare diseases, and pediatrics. Their services include clinical studies, biomarkers strategy, companion diagnostics, regulatory and strategic consulting, analytical testing, commercialization support, and post-approval planning. Covance has experience conducting over 40 clinical studies of gene and cell therapies across the US, Europe and Asia involving over 1,100 patients at 263 sites.